Radiotherapy Combined With Almonertinib for Stage III EGFR-Mutated Lung Cancer
- First Posted Date
- 2023-08-16
- Last Posted Date
- 2023-08-29
- Lead Sponsor
- Laibin People's Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT05994339
A Retrospective Study of Radiotherapy Combined With EGFR-TKI for Stage III EGFR Mutant Lung Cancer
Completed
- Conditions
- The Primary Study Metric is Progression-free Survival (PFS)
- First Posted Date
- 2023-07-07
- Last Posted Date
- 2023-07-07
- Lead Sponsor
- Laibin People's Hospital
- Target Recruit Count
- 48
- Registration Number
- NCT05934461
© Copyright 2025. All Rights Reserved by MedPath